These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11147695)

  • 1. Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events.
    Goebel J; Stevens E; Forrest K; Roszman TL
    Transpl Immunol; 2000 Nov; 8(3):153-9. PubMed ID: 11147695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling.
    Tkaczuk J; Yu CL; Baksh S; Milford EL; Carpenter CB; Burakoff SJ; McKay DB
    Am J Transplant; 2002 Jan; 2(1):31-40. PubMed ID: 12095053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular signaling consequences of anti-IL-2Ralpha blockade by daclizumab.
    Tkaczuk J; Milford E; Yu C; Baksh S; Carpenter C; Burakoff S; McKay D
    Transplant Proc; 2001; 33(1-2):212-3. PubMed ID: 11266783
    [No Abstract]   [Full Text] [Related]  

  • 5. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.
    Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M
    Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daclizumab: a potential asthma therapy?
    Antoniu SA
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):214-21. PubMed ID: 20804450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.
    Liu KD; Lai SY; Goldsmith MA; Greene WC
    J Biol Chem; 1995 Sep; 270(38):22176-81. PubMed ID: 7545674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A
    Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients.
    Baan CC; Balk AH; van der Plas AJ; van Gelder T; Vantrimpont PJ; Maat LP; Weimar W
    Transplant Proc; 2002 Dec; 34(8):3243-5. PubMed ID: 12493434
    [No Abstract]   [Full Text] [Related]  

  • 12. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.
    Gaffen SL; Lai SY; Xu W; Gouilleux F; Groner B; Goldsmith MA; Greene WC
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7192-6. PubMed ID: 7543676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
    Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW
    Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daclizumab therapy in kidney transplantation-different mechanisms of action in- versus ex-vivo?
    Forrest K; Logan B; Strange J; Roszman TL; Goebel J
    Transpl Immunol; 2005 Mar; 14(1):43-7. PubMed ID: 15814281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy.
    Wuest SC; Edwan JH; Martin JF; Han S; Perry JS; Cartagena CM; Matsuura E; Maric D; Waldmann TA; Bielekova B
    Nat Med; 2011 May; 17(5):604-9. PubMed ID: 21532597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
    Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
    Delespine-Carmagnat M; Bouvier G; Bertoglio J
    Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.